Biotechnology and Biopharmaceuticals - Protein Drugs and Gene Drugs

Author: Humayun Beg, King of the Khilji
Publisher:
Publish Date: 2006-01-01
Features:
· Provides detailed information on over 60 biologic drugs.
· Offers insights and concepts applicable to pharmaceutical technology and biologic drug development processes.
· Explores how biotechnology and recombinant molecules progress from concept to product.
· Highlights the technical and commercial characteristics of biologic drug development.
· Discusses cell/gene therapy and genomics/proteomics in drug discovery.
The book is divided into four parts.
Part 1 introduces the aspects of biopolymers becoming therapeutic drugs, with a focus on the significant differences between biologic and small-molecule drugs in the drug discovery and development stages.
Part 2 provides an overview of FDA-approved biologic drugs—where the general section briefly reviews their physiological effects and clinical applications, and the specific section lists detailed information on each drug within each class.
Part 3 emphasizes the optimization of biologic drug delivery technologies and appropriately covers gene and cell therapies.
Part 4 includes five appendices: "Dosage Forms, Pharmacokinetic and Metabolic Data," "Molecular Characteristics and Therapeutic Uses," "Naming Methods for Biotechnology Products," "Synonyms of Trade Names, Common Names, and Scientific Names," and other information.
This book is suitable for professionals engaged in biologic drug research, development, and production, as well as university teachers, undergraduates, and graduate students in related fields.